… At present, there are some differences in the research results of molnupiravir. The purpose
of this study was to evaluate the efficacy and safety of molnupiravir in the treatment of COVID-…

… Molnupiravir is an oral antiviral drug that received Emergency Use … treatment of mild
COVID-19. The aim of this systematic review was to find out the safety and efficacy of Molnupiravir in …

… Our analysis does not support routine use of molnupiravir for COVID-19 treatment in …
outpatients with risk factors treated with molnupiravir. Moreover, safety concerns have been raised …

… efficacy and safety of molnupiravir in COVID-19 patients. The primary findings of our study
indicate that molnupiravir … -immunomodulatory direct antiviral treatments, molnupiravir did not …

… that molnupiravir was effective in treating COVID-19 caused by Omicron variant infection,
with few adverse effects. Compared to basic treatment, molnupiravir treatment significantly …

… the impetus behind our investigations with molnupiravir. Molnupiravir has been shown to be
… In this study, we evaluate the efficacy and safety of molnupiravir in Indian patients with mild …

… Therefore, molnupiravir still plays a key role in the treatment of … demonstrated that early
molnupiravir treatment is effective in … efficacy of molnupiravir in treating patients with COVID-19. …

… Our study shows the efficacy and safety of molnupiravir in a real-life cohort that included a
high percentage of elderly people with a high comorbidity burden. However, more studies are …

… , is being repurposed for the treatment of COVID-19. This study evaluates the efficacy
and safety of molnupiravir in addition to the standard-of-care (SOC) for the treatment of non-…

… Finally, we found that about 2% of patients treated with nirmatrelvir/ritonavir and molnupiravir
experienced a rebound of symptoms after the antiviral discontinuation. Here, we only …